Is Waters Corporation (NYSE:WAT) a buy in 2026?
Hold. Waters Corporation is a wait-and-watch at today's price, not a fresh buy.
Becton merger creates a life sciences tools giant, but integration math and 23x forward earnings leave little room for error.
Where WAT is headed
The Waters you knew, the sleepy Milford maker of liquid chromatography systems for pharma QA labs, no longer exists as of the Becton Dickinson Biosciences and Diagnostic Solutions combination that closed earlier this year. The +91% revenue growth print is the merger arithmetic showing up. What sits on the balance sheet now is a roughly $7bn revenue analytical tools company with a combined instrument base spanning LC, mass spec, flow cytometry, and molecular diagnostics, sold into the same pharma, biotech, and clinical customers that Waters spent 60 years cultivating. Management's pitch is $345m in cost synergies by year three and $290m in revenue synergies by year five. That is the number the stock is currently underwriting at $379.
Read the full Compass Direction on WAT
The complete destination call, the overlooked angle, milestones, and bull, base, and bear price scenarios (around $368.87).
See the full WAT analysisGet calls like this, free
Join the Alexandria e-letter for forward-looking verdicts, earnings intelligence, and the contrarian reads the crowd misses. Twice a week, no noise.
Free forever. Unsubscribe anytime. We never share your email.
Frequently asked questions
Is Waters Corporation (NYSE:WAT) a buy in 2026?
Hold. Waters Corporation is a wait-and-watch at today's price, not a fresh buy. Becton merger creates a life sciences tools giant, but integration math and 23x forward earnings leave little room for error.
What is WAT's Compass Score?
Waters Corporation scores 77/100 on Alexandria's Compass, placing it in the "Favorable" tier. Scores blend eight factors and update weekly.
What is the price target for WAT?
Alexandria's full Compass Direction includes bull, base, and bear price scenarios with the valuation math behind each. Read the full breakdown on the WAT page.
Compass verdicts are AI-generated, forward-looking editorial research from publicly available data, not investment advice or a recommendation regarding any security. Scores and verdicts update as the data changes.